Carl Gardiner has been a financial analyst for over 18 years, including eight years in investment analysis and management. Prior to joining Schafer Cullen Capital Management, he was an investment analyst and portfolio manager at two research-driven, value-oriented investment funds, Copper Arch Capital and North Sound Capital. From 1992 to 2000, he was a Director at Merrill Lynch, as an investment banker in New York and London. Mr. Gardiner began his career at Fox Asset Management, a value-oriented money management firm. He received a MA degree in International Economics from Johns Hopkins School of Advanced International Studies in 1992 and a BA degree with High Honors from the University of Virginia in 1989.
TWST: Would you be able to give us any examples of the type of companies that are like core holdings or new acquisitions?
There are far fewer of those just lopsided, obviously mispriced opportunities, so we are now back more into our normal mode of finding situations that are overlooked. In this vein, the last stock I’d mention is our most recent purchase, Omnicare (OCR). Omnicare trades at a little over 9 times 2009 earnings, with a $2.8 billion market value. Omnicare is the largest institutional pharmacy in the US, serving skilled nursing facilities and assisted living facilities, with a 50% share of this market. There are some interesting things going on at Omnicare that have great potential to boost returns over the next two to three years. Most importantly, having consolidated the industry, the company is finally taking advantage of its scale. Omnicare is nearly through an initiative to automate and centralize certain repetitive functions, so that it can downsize its over 200 regional pharmacies saving over $100mm a year in costs and freeing resource for customer retention activity. Omnicare has a number of other cost-saving initiatives underway as well. Finally, the wave of branded drugs going generic gives Omnicare a gross profit lift, and while this has been underway for the past few years, there is still some runway here.
Martin Midstream Partners L.P. (MMLP) Has Long Track Record of Success and Institutional Investors Scooping Up Units
July 03, 2013
Warren Buffett, Graham and Dodd and Now, Sound Shore Management: Classic Value Investors are Happy Investors
September 05, 2022
Investors Missing Opportunity in Front of athenahealth, Inc (ATHN)
May 16, 2014
Contrarian Investors May Find Opportunity in First Solar, Inc. (FSLR)
February 24, 2015
New Triumph Group Inc (TGI) CEO Could Mean Opportunity for Investors
June 09, 2015
